Molecular Formula | C25H37NO3 |
Molar Mass | 399.57 |
Density | 1.13±0.1 g/cm3(Predicted) |
Melting Point | 242-249° |
Boling Point | 596.0±50.0 °C(Predicted) |
pKa | 4.8(at 25℃) |
Storage Condition | 2-8℃ |
Physical and Chemical Properties | White crystals are obtained from ethyl acetate with a melting point of 242~249 ℃. pK4.8. |
Use | It is a treatment for benign prostatic hyperplasia. It is a strong inhibitor of type 2 sterol 5 α-reductase and has weak inhibitory power on type 1 enzyme. Testosterone reductase inhibitors. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.503 ml | 12.514 ml | 25.027 ml |
5 mM | 0.501 ml | 2.503 ml | 5.005 ml |
10 mM | 0.25 ml | 1.251 ml | 2.503 ml |
5 mM | 0.05 ml | 0.25 ml | 0.501 ml |
Biological activity
Epristeride is a new type of 5 α-reductase inhibitor.
Target
5α-reductase
Chemical properties
white crystal from ethyl acetate, melting point 242~249 ℃. pK4.8.
Production method
3-oxoandrost-4-ene-17 β-carboxylic acid methyl ester (Ⅰ) is treated with phosphorus tribromide in glacial acetic acid, converted into compound (Ⅱ), and then hydrolyzed into compound (Ⅲ). First react with oxalyl chloride, and then tert-butylamine is quenched to obtain compound (Ⅳ). (Ⅳ) After treatment with ethyl magnesium bromide, adding sec-butyl lithium, and using carbon dioxide for halogen metal exchange reaction, the crude product of eriandrostine is obtained. The crude product can be heated and refined in ethyl acetate.
biological activity | Epristeride is a new type of 5 α-reductase inhibitor. |
target | 5α-reductase |
chemical properties | white crystal from ethyl acetate, melting point 242~249 ℃. pK4.8. |
use | is a therapeutic drug for benign prostatic hyperplasia. It is a strong inhibitor of type 2 sterol 5 α-reductase and has weak inhibitory power on type 1 enzyme. Testosterone reductase inhibitor. |
Production method | 3-oxoandrost-4-ene-17 β-carboxylic acid methyl ester (Ⅰ) is treated with phosphorus tribromide in glacial acetic acid, converted into compound (Ⅱ), and then hydrolyzed into compound (Ⅲ). First react with oxalyl chloride, and then tert-butylamine is quenched to obtain compound (Ⅳ). (Ⅳ) After treatment with ethyl magnesium bromide, adding sec-butyl lithium, and using carbon dioxide for halogen metal exchange reaction, the crude product of eriandrostine is obtained. The crude product can be heated and refined in ethyl acetate. |